Traditional Chinese Herbal Medicine and Corticosteroids in Asthma: A short review.
Article Sidebar
Main Article Content
Abstract
Asthma is a prevalent chronic inflammatory disease that has gold standard treatment with corticosteroids, but these are associated with important long-term side effects. On this basis, Traditional Chinese Medicine contributes with therapeutic techniques such as the herbal Anti-Asthma Herbal Medicine Intervention (ASHMI). In this context, this study aims to evaluate the effectiveness of treatment with ASHMI compared to conventional therapy, considering the need for new therapeutic approaches. An integrative review was performed, according to the PRISMA methodology (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Articles published between 2011 and 2021 that related Herbal Medicines of Traditional Chinese Medicine, asthma and corticosteroids were examined. The searches took place in October and November 2021 in the Scopus, PubMed, Web of Science, Google Scholar, and Scielo databases. The selection comprised steps such as: search, pre-selection and inclusion of articles. The results of the herbal medicine and its isolated components were demonstrated, with three studies being clinical trials with humans and four pre-clinical studies. From the results, the efficacy of the herbal medicine and its components compared to corticosteroids were evaluated. It was reported that ASHMI, unlike corticosteroids, does not suppress the hypothalamic-pituitary-adrenal axis and the immune system, having mild adverse effects and significant inflammatory response, albeit late. The components showed positive responses in inhibiting asthma inflammation, which improved symptoms and quality of life. In conclusion, ASHMI, in addition to being effective for asthma, also showed safety and tolerability when compared to corticosteroids with long-term effects.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright Statement - Policy Proposal for Open Access Journals
Authors who publish in the Brazilian Journal of Natural Sciences (BJNS) agree to the following terms: 1 - Authors retain the copyright and grant the journal the right to first publication, with the work simultaneously licensed under the Creative Commons Attribution License allowing sharing of the work with recognition of the authorship of the work and initial publication in this journal. 2 - Authors are authorized to assume additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (eg, publishing in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal. 3 - Authors are allowed and encouraged to publish and distribute their work online (eg in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes, as well as increase the impact and citation of published work. This is an open access article under the CC-BY license
(http://creativecommons.org/licenses/by/4.0)
References
- World Health Organization. Asma. Acess in 29 oct 2021. Available in https://www.who.int/news-room/fact-sheets/detail/asthma.
- Leonard P, Sur S. Asthma: future directions. Med Clin North Am. 2002 Sep;86(5):1131-56. Acess in 29 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/12428548/.
- Heffler E, Madeira LNG, Ferrando M, Puggioni F, Racca F, Malvezzi L, Passalacqua G, Canonica GW. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma. J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):776-781. Acess in 29 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/29408385/.
- Meneses AS. Chinese Herbal Medicine. [Dissertation]. Porto: UFP; 2016.
- Hong ML, Song Y, Li XM. Effects and mechanisms of actions of Chinese herbal medicines for asthma. Chin J Integr Med. 2011 Jul;17(7):483-91. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/21725872/.
- Kelly-Pieper K, Patil SP, Busse P, Yang N, Sampson H, Li XM, Wisnivesky JP, Kattan M. Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study. J Altern Complement Med. 2009 Jul;15(7):735-43. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/19586409/.
- Wen MC, Wei CH, Hu ZQ, Srivastava K, Ko J, Xi ST, Mu DZ, Du JB, Li GH, Wallenstein S, Sampson H, Kattan M, Li XM. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol. 2005 Sep;116(3):517-24. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/16159618/.
-Jayaprakasam B, Yang N, Wen MC, Wang R, Goldfarb J, Sampson H, Li XM. Constituents of the anti-asthma herbal formula ASHMI(TM) synergistically inhibit IL-4 and IL-5 secretion by murine Th2 memory cells, and eotaxin by human lung fibroblasts in vitro. J Integr Med. 2013 May;11(3):195-205. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/23743163/.
- Srivastava KD, Dunkin D, Liu C, Yang N, Miller RL, Sampson HA, Li XM. Effect of Antiasthma Simplified Herbal Medicine Intervention on neutrophil predominant airway inflammation in a ragweed sensitized murine asthma model. Ann Allergy Asthma Immunol. 2014 Apr;112(4):339-47.e1-2. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/24679734/.
- Hoang BX, Shaw DG, Levine S, Hoang C, Pham P. New approach in asthma treatment using excitatory modulator. Phytother Res. 2007 Jun;21(6):554-7. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/17295384/.
- Hong MH, Lee JY, Jung H, Jin DH, Go HY, Kim JH, Jang BH, Shin YC, Ko SG. Sophora flavescens Aiton inhibits the production of pro-inflammatory cytokines through inhibition of the NF kappaB/IkappaB signal pathway in human mast cell line (HMC-1). Toxicol In Vitro. 2009 Mar;23(2):251-8. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/19118619/.
- Liu F, Xuan NX, Ying SM, Li W, Chen ZH, Shen HH. Herbal Medicines for Asthmatic Inflammation: From Basic Researches to Clinical Applications. Mediators Inflamm. 2016;2016:6943135. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/27478309/.
- Liu C, Yang N, Song Y, Wang L, Zi J, Zhang S, Dunkin D, Busse P, Weir D, Tversky J, Miller RL, Goldfarb J, Zhan J, Li XM. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-α production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. Int Immunopharmacol. 2015 Aug;27(2):224-31. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/26004313/.
- Zhang Y, Wang X, Zhang H, Tang H, Hu H, Wang S, Wong VKW, Li Y, Deng J. Autophagy Modulators From Chinese Herbal Medicines: Mechanisms and Therapeutic Potentials for Asthma. Front Pharmacol. 2021 Jul 23;12:710679. Acess in 15 oct 2021. Available in https://pubmed.ncbi.nlm.nih.gov/34366865/.
Maria Pia GD, Sara F, Mario F, Lorenza S. Biological Effects of Licochalcones. Mini Rev Med Chem. 2019;19(8):647-656. doi: 10.2174/1389557518666180601095420. PMID: 30049263.
Yang R, Yuan BC, Ma YS, Zhou S, Liu Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm Biol. 2017 Dec;55(1):5-18. doi: 10.1080/13880209.2016.1225775. Epub 2016 Sep 21. PMID: 27650551; PMCID: PMC7012004.